Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  López, Virginia ^a   González Peramato, Pilar ^b   Suela, Javier ^a   Serrano, Alvaro ^c   Algaba, Ferrán ^d   Cigudosa, Juan C ^a   Vidal, August ^e   Bellmunt, Joaquim ^f   Heredero, Oscar ^g   Sánchez Carbayo, Marta ^a,h  

^a Centro Nacional de Investigations Oncológicas   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^d FUNDACIÓ PUIGVERT   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f HOSPITAL DEL MAR   (Spain)

^g HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^h CIC BIOGUNE   (Spain)

Author keywords

Array CGH; Bladder cancer; FISH; Immunohistochemistry; Tissue arrays; Urine

Indexed keywords

CHAPERONE; DNA; PREFOLDIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER STAGING; CHROMOSOMAL LOCALIZATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA DETERMINATION; DNA MICROARRAY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENE LOSS; GENE MUTATION; GENE OVEREXPRESSION; GENETIC GAIN; GENETIC IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PFND2 GENE; TISSUE MICROARRAY; URINALYSIS; VALIDATION PROCESS;

BIOLOGICAL MARKERS; CHROMOSOMES, HUMAN, PAIR 1; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MOLECULAR CHAPERONES; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84880944047     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-182     Document Type: Article

References (56)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics 2012. CA Cancer J Clin 2012, 62:10-29. 10.3322/caac.20138, 22237781.
2. Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, Kiemeney L, Kriegmair M, Montironi R, Murphy WM, Sesterhenn IA, Tachibana M, Weider J. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005, 66:4-34.
3. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992, 258:818-821. 10.1126/science.1359641, 1359641.
4. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, Gray JW, Albertson DG. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998, 20:207-211. 10.1038/2524, 9771718.
5. Kallioniemi A, Kallioniemi OP, Citro G, Sauter G, DeVries S, Kerschmann R, Caroll P, Waldman F. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer 1995, 12:213-219. 10.1002/gcc.2870120309, 7536461.
6. Voorter C, Joos S, Bringuier PP, Vallinga M, Poddighe P, Schalken J, du Manoir S, Ramaekers F, Lichter P, Hopman A. Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Am J Pathol 1995, 146:1341-1354. 1870895, 7778674.
7. Obermann EC, Junker K, Stoehr R, Dietmaier W, Zaak D, Schubert J, Hofstaedter F, Knuechel R, Hartmann A. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses. J Pathol 2003, 199:50-57. 10.1002/path.1259, 12474226.
8. Constantinou M, Binka-Kowalska A, Borkowska E, Zajac E, Jałmuzna P, Matych J, Nawrocka A, Kałuzewski B. Application of multiplex FISH, CGH and MSSCP techniques for cytogenetic and molecular analysis of transitional cell carcinoma (TCC) cells in voided urine specimens. J Appl Genet 2006, 47:273-275. 10.1007/BF03194636, 16877809.
9. Junker K, van Oers JM, Zwarthoff EC, Kania I, Schubert J, Hartmann A. Fibroblast growth factor receptor 3 mutations in bladder tumors correlate with low frequency of chromosome alterations. Neoplasia 2008, 10:1-7. 10.1593/neo.07178, 2213896, 18231634.
10. El-Rifai W, Kamel D, Larramendy ML, Shoman S, Gad Y, Baithun S, El-Awady M, Eissa S, Khaled H, Soloneski S, Sheaff M, Knuutila S. DNA copy number changes in Schistosoma-associated and non-Schistosoma-associated bladder cancer. Am J Pathol 2000, 156:871-878. 10.1016/S0002-9440(10)64956-5, 1876852, 10702404.
11. Richter J, Jiang F, Görög JP, Sartorius G, Egenter C, Gasser TC, Moch H, Mihatsch MJ, Sauter G. Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res 1997, 57:2860-2864.
12. Richter J, Beffa L, Wagner U, Schraml P, Gasser TC, Moch H, Mihatsch MJ, Sauter G. Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Am J Pathol 1998, 153:1615-1621. 10.1016/S0002-9440(10)65750-1, 1853402, 9811354.
13. Simon R, Bürger H, Brinkschmidt C, Böcker W, Hertle L, Terpe HJ. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol 1998, 185:345-351. 10.1002/(SICI)1096-9896(199808)185:4<345::AID-PATH109>3.0.CO;2-0, 9828832.
14. Muscheck M, Abol-Enein H, Chew K, Moore D, Bhargava V, Ghoneim MA, Carroll PR, Waldman FM. Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization. Carcinogenesis 2000, 21:1721-1726. 10.1093/carcin/21.9.1721, 10964104.
15. Fadl-Elmula I, Kytola S, Leithy ME, Abdel-Hameed M, Mandahl N, Elagib A, Ibrahim M, Larsson C, Heim S. Chromosomal aberrations in benign and malignant bilharzia-associated bladder lesions analyzed by comparative genomic hybridization. BMC Cancer 2002, 2:5. 10.1186/1471-2407-2-5, 101388, 11914143.
16. Harding M, Arden K, Gildea JW, Gildea JJ, Perlman EJ, Viars C, Theodorescu D. Functional Genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling. Cancer Res 2002, 62:6981-6989.
17. Wang X, Ling MT, Guan XY, Tsao SW, Cheung HW, Lee DT, Wong YC. Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells. Oncogene 2004, 23:474-482. 10.1038/sj.onc.1207128, 14724576.
18. Wu Z, Siadaty MS, Riddick G, Frierson HF, Lee JK, Golden W, Knuutila S, Hampton GM, El-Rifai W, Theodorescu D. A novel method for gene expression mapping of metastatic competence in human bladder cancer. Neoplasia 2006, 8:181-189. 10.1593/neo.05727, 1578518, 16611411.
19. Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, DeVries S, Carroll P, Kuo WL, Pinkel D, Albertson D, Cordon-Cardo C, Jain AN, Waldman FM. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res 2003, 63:2872-2880.
20. Hupé P, Stransky N, Thiery JP, Radvanyi F, Barillot E. Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics 2004, 20:3413-3422. 10.1093/bioinformatics/bth418, 15381628.
21. Blaveri E, Brewer JL, Roydasgupta R, Fridlyand J, DeVries S, Koppie T, Pejavar S, Mehta K, Carroll P, Simko JP, Waldman FM. Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res 2005, 11:7012-7022. 10.1158/1078-0432.CCR-05-0177, 16203795.
22. Stransky N, Vallot C, Reyal F, Bernard-Pierrot I, de Medina SG, Segraves R, de Rycke Y, Elvin P, Cassidy A, Spraggon C, Graham A, Southgate J, Asselain B, Allory Y, Abbou CC, Albertson DG, Thiery JP, Chopin DK, Pinkel D, Radvanyi F. Regional copy number-independent deregulation of transcription in cancer. Nat Genet 2006, 38:1386-1396. 10.1038/ng1923, 17099711.
23. Yamamoto Y, Chochi Y, Matsuyama H, Eguchi S, Kawauchi S, Furuya T, Oga A, Kang JJ, Naito K, Sasaki K. Gain of 5p15.33 is associated with progression of bladder cancer. Oncology 2007, 72:132-138.
24. Hurst CD, Tomlinson DC, Williams SV, Platt FM, Knowles MA. Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification. Oncogene 2008, 27:2716-2727. 10.1038/sj.onc.1210934, 2387074, 18037967.
25. Hurst CD, Fiegler H, Carr P, Williams S, Carter NP, Knowles MA. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization. Oncogene 2004, 23:2250-2263. 10.1038/sj.onc.1207260, 14968109.
26. Shinoda Y, Kozaki K, Imoto I, Obara W, Tsuda H, Mizutani Y, Shuin T, Fujioka T, Miki T, Inazawa J. Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cells. Cancer Sci 2007, 98:1078-1086. 10.1111/j.1349-7006.2007.00495.x, 17459052.
27. Vauhkonen H, Böhling T, Eissa S, Shoman S, Knuutila S. Can bladder adenocarcinomas be distinguished from schistosomiasis-associated bladder cancers by using array comparative genomic hybridization analysis?. Cancer Genet Cytogenet 2007, 177:153-157. 10.1016/j.cancergencyto.2007.06.017, 17854674.
28. Larré S, Camparo P, Comperat E, Gil Diez De Medina S, Traxer O, Roupret M, Sebe P, Cancel-Tassin G, Sighar K, Lozach F, Cussenot O. Diagnostic, staging, and grading of urothelial carcinomas from urine: performance of BCA-1, a mini-array comparative genomic hybridisation-based test. Eur Urol 2011, 59:250-257. 10.1016/j.eururo.2010.10.007, 21056532.
29. Herrero J, Al-Shahrour F, Díaz-Uriarte R, Mateos A, Vaquerizas JM, Santoyo J, Dopazo J. A web-based resource for microarray gene expression data analysis. Nucleic Acids Res 2003, 31:3461-3467. 10.1093/nar/gkg591, 168997, 12824345.
30. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Statistical Society 1995, 57:289-300.
31. Sanchez-Carbayo M, Socci ND, Charytonowicz E, Lu M, Prystowsky M, Childs G, Cordon-Cardo C. Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. Cancer Res 2002, 62:6973-6980.
32. Dawson-Saunders B, Trapp RG. Basic and Clinical Biostatistics 1994, Norwalk, Connecticut: Appleton & Lange, 2.
33. Dalbagni G, Presti J, Reuter V, Fair WR, Cordon-Cardo C. Genetic alterations in bladder cancer. Lancet 1993, 324:469-471.
34. Savelieva E, Belair CD, Newton MA, DeVries S, Gray JW, Waldman F, Reznikoff CA. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells. Oncogene 1997, 14:551-560. 10.1038/sj.onc.1200868, 9053853.
35. Richter J, Wagner U, Kononen J, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knönagel H, Rist M, Wilber K, Anabitarte M, Hering F, Hardmeier T, Schönenberger A, Flury R, Jäger P, Fehr JL, Schraml P, Moch H, Mihatsch MJ, Gasser T, Kallioniemi OP, Sauter G. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol 2000, 157:787-794. 10.1016/S0002-9440(10)64592-0, 1885698, 10980118.
36. Bruch J, Wöhr G, Hautmann R, Mattfeldt T, Brüderlein S, Möller P, Sauter S, Hameister H, Vogel W, Paiss T. Chromosomal changes during progression of transitional cell carcinoma of the bladder and delineation of the amplified interval on chromosome arm 8q. Genes Chromosomes Cancer 1998, 23:167-174. 10.1002/(SICI)1098-2264(199810)23:2<167::AID-GCC10>3.0.CO;2-L, 9739020.
37. Yeager TR, De Vries S, Jarrard DF, Kao C, Nakada SY, Moon TD, Bruskewitz R, Stadler WM, Meisner LF, Gilchrist KW, Newton MA, Waldman FM, Reznikoff CA. Overcoming cellular senescence in human cancer pathogenesis. Genes Dev 1998, 12:163-174. 10.1101/gad.12.2.163, 316442, 9436977.
38. Koo SH, Kwon KC, Ihm CH, Jeon YM, Park JW, Sul CK. Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis. Cancer Genet Cytogenet 1999, 110:87-93. 10.1016/S0165-4608(98)00193-9, 10214355.
39. Terracciano L, Richter J, Tornillo L, Beffa L, Diener PA, Maurer R, Gasser TC, Moch H, Mihatsch MJ, Sauter G. Chromosomal imbalances in small cell carcinomas of the urinary bladder. J Pathol 1999, 189:230-235. 10.1002/(SICI)1096-9896(199910)189:2<230::AID-PATH407>3.0.CO;2-8, 10547580.
40. Williams SV, Adams J, Coulter J, Summersgill BM, Shipley J, Knowles MA. Assessment by M-FISH of karyotypic complexity and cytogenetic evolution in bladder cancer in vitro. Genes Chromosomes Cancer 2005, 43:315-328. 10.1002/gcc.20166, 15846775.
41. Appanna TC, Doak SH, Jenkins SA, Kynaston HG, Stephenson TP, Parry JM. Comparative genomic hybridization (CGH) of augmentation cystoplasties. Int J Urol 2007, 14:539-544. 10.1111/j.1442-2042.2006.01724.x, 17593101.
42. Dahse R, Gärtner D, Werner W, Schubert J, Junker K. P53 mutations as an identification marker for the clonal origin of bladder tumors and its recurrences. Oncol Rep 2003, 10:2033-2037.
43. Pinkel D, Albertson DG. Array comparative genomic hybridization and its applications in cancer. Nat Genet 2005, 37:S11-S17. 10.1038/ng1569, 15920524.
44. Vainberg IE, Lewis SA, Rommelaere H, Ampe C, Vandekerckhove J, Klein HL, Cowan NJ. Prefoldin, a chaperone that delivers unfolded proteins to cytosolic chaperonin. Cell 1998, 93:863-873. 10.1016/S0092-8674(00)81446-4, 9630229.
45. Hansen WJ, Cowan NJ, Welch WJ. Prefoldin-nascent chain complexes in the folding of cytoskeletal proteins. J Cell Biol 1999, 145:265-277. 10.1083/jcb.145.2.265, 2133115, 10209023.
46. Muhua L, Karpova TS, Cooper JA. A yeast actin-related protein homologous to that in vertebrate dynactin complex is important for spindle orientation and nuclear migration. Cell 1994, 78:669-679. 10.1016/0092-8674(94)90531-2, 8069915.
47. Moreau V, Madania A, Martin RP, Winson B. The Saccharomyces cerevisiae actin-related protein Arp2 is involved in the actin cytoskeleton. J Cell Biol 1996, 134:117-132. 10.1083/jcb.134.1.117, 2120930, 8698808.
48. Fryer CJ, Archer TK. Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature 1998, 393:88-91. 10.1038/30032, 9590696.
49. Peterson CL, Zhao Y, Chait BT. Subunits of the yeast SWI/SNF complex are members of the actin-related protein (ARP) family. J Biol Chem 1998, 273:23641-23644. 10.1074/jbc.273.37.23641, 9726966.
50. Takahashi M, Watari E, Shinya E, Shimizu T, Takahashi H. Suppression of virus replication via down-modulation of mitochondrial short chain enoyl-CoA hydratase in human glioblastoma cells. Antiviral Res 2007, 75:152-158. 10.1016/j.antiviral.2007.02.002, 17395278.
51. Collins C, Volik S, Kowbel D, Ginzinger D, Ylstra B, Cloutier T, Hawkins T, Predki P, Martin C, Wernick M, Kuo WL, Alberts A, Gray JW. Comprehensive genome sequence analysis of a breast cancer amplicon. Genome Res 2001, 11:1034-1042. 10.1101/gr.GR1743R, 311107, 11381030.
52. Alldinger I, Dittert D, Peiper M, Fusco A, Chiappetta G, Staub E, Lohr M, Jesnowski R, Baretton G, Ockert D, Saeger HD, Grützmann R, Pilarsky C. Gene expression analysis of pancreatic cell lines reveals genes overexpressed in pancreatic cancer. Pancreatology 2005, 5:370-379. 10.1159/000086537, 15983444.
53. Ostrov DA, Barnes CL, Smith LE, Binns S, Brusko TM, Brown AC, Quint PS, Litherland SA, Roopenian DC, Iczkowski KA. Characterization of HKE2: an ancient antigen encoded in the major histocompatibility complex. Tissue Antigens 2007, 69:181-188. 10.1111/j.1399-0039.2006.00730.x, 17257322.
54. Kurata M, Maesako Y, Ueda C, Nishikori M, Akasaka T, Uchiyama T, Ohno H. Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6. Cancer Res 2002, 62:6224-6230.
55. Myung JK, Afjehi-Sadat L, Felizardo-Cabatic M, Slavc I, Lubec G. Expressional patterns of chaperones in ten human tumor cell lines. Proteome Sci 2004, 2:8. 10.1186/1477-5956-2-8, 543454, 15598346.
56. Cimmino F, Spano D, Capasso M, Zambrano N, Russo R, Zollo M, Iolascon A. Comparative proteomic expression profile in all-trans retinoic acid differentiated neuroblastoma cell line. J Proteome Res 2007, 6:2550-2564. 10.1021/pr060701g, 17559250.